Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma.
BACKGROUND
Chronic infection by hepatitis B virus (HBV) is the leading cause of hepatocellular carcinoma (HCC) in man. The viral transactivator HBV X (HBx) gene plays a critical role in the molecular pathogenesis of HBV-related HCC.


OBJECTIVE
The aim of this study was to investigate whether there were particular HBx mutations associated with the Chinese Hong Kong patients with HCC.


METHODS
We have examined HBx in 113 tumor tissue samples from patients with HCC and 48 serum samples from the same group. In addition, we also examined the expression of HBx protein and the index of apoptotic cell death in tumor tissues of HCC. The entire coding region of HBx gene from the sample was sequenced and aligned with the published HBx gene sequence.


CONCLUSIONS
We have identified total 54 different types of mutations in HBx gene. HBx mutations occurred in a very high percentage of samples tested. Mutation of HBx was found in 95.2% and 95.3% of the tumor tissue and serum samples, respectively. Most of samples contained more than one type of the mutation. Relative risk analysis indicated that the mutations in 12 sites of tissue HBx and nine sites of serum HBx were highly associated with HCC, suggesting a potential role of these mutants in carcinogenesis. An insert mutation at position 204: Insert 204AGGCCC, was always found to co-exist with point mutations at 260 (G-->A) and 264 (G/C/T-->A). Furthermore, this particular pattern of HBx mutation was most frequently detected. Immunochemical staining of HBx protein revealed that the nuclear localization of HBx protein in hepatocytes of tumor tissues was highly associated with this particular pattern of HBx mutation. In conclusion, HBx mutation occurs frequently in HCC samples tested and a sample usually has multiple types of mutations. A special pattern of insert at 204 and point mutations at 260 and 264 was identified, and it appears to be associated with the nuclear localization of HBx protein. The development of multiple types of mutations in a given sample may contribute to the process of multiple steps in hepatocarcinogenesis.
Chen
G G
GG
Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Room 306 Cancer Center, Shatin, New Territories, Hong Kong. gchen@cuhk.edu.hk
Li
M Y
MY
Ho
R L K
RL
Chak
E C W
EC
Lau
W Y
WY
Lai
P B S
PB
D001483:Base Sequence; D006528:Carcinoma, Hepatocellular / Q000097:blood / Q000821:virology*; D017931:DNA Primers; D004251:DNA Transposable Elements; D004279:DNA, Viral / Q000235:genetics / Q000302:isolation & purification; D005814:Genes, Viral; D006509:Hepatitis B / Q000150:complications*; D006723:Hong Kong; D006801:Humans; D008113:Liver Neoplasms / Q000097:blood / Q000821:virology*; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D020641:Polymorphism, Single Nucleotide; D012306:Risk; D015534:Trans-Activators / Q000235:genetics* / Q000302:isolation & purification; D054334:Viral Regulatory and Accessory Proteins
D017931:DNA Primers; D004251:DNA Transposable Elements; D004279:DNA, Viral; D015534:Trans-Activators; D054334:Viral Regulatory and Accessory Proteins; C057628:hepatitis B virus X protein